article thumbnail

Herd immunity is nice – but what about me?

pharmaphorum

Shahrokh Shabahang discusses why we need a personalised approach to COVID-19 immunity testing. While these numbers do tell us something about the relative immunity of the population writ large, they don’t tell us anything about our own, personal immune profiles. What does that mean in real-world terms?

article thumbnail

EC approves Regeneron’s immunotherapy for cervical cancer

Pharmaceutical Technology

Additionally, 21% of subjects who received Libtayo had immune-mediated adverse reactions. Hypothyroidism, hyperthyroidism, immune-mediated pneumonitis, hepatitis, colitis and skin adverse reactions were reported to be the most frequent immune-mediated adverse reactions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How pharmacists can counsel patients on a bad reaction to a new medication

The Checkup by Singlecare

The first step in identifying or managing a medication reaction is knowing what you’re dealing with. Drug reactions may be immunologic or non-immunologic. Meaning, they may be caused by the immune system or other factors. . Immunologic reactions. Nonimmunologic reactions. Most common culprits of reactions.

article thumbnail

Important information about Dupixent and vaccines

The Checkup by Singlecare

Dupixent works by moderating the immune system—and that can interfere with how your body responds to certain vaccinations. How Dupixent works in the body “People with autoimmune diseases have an immune system that essentially overreacts to certain triggers,” says Jody A. Can you get vaccinated while taking Dupixent?

article thumbnail

US FDA approves Apellis’ geographic atrophy therapy Syfovre

Pharmaceutical Technology

It provides comprehensive control of the complement cascade, which is part of the immune system of the body, by targeting C3. Vitreous floaters, ocular discomfort, conjunctival hemorrhage, and neovascular AMD were the most common adverse reactions observed in patients receiving Syfovre.

FDA 98
article thumbnail

EC approves Libtayo® for metastatic cervical cancer

European Pharmaceutical Review

Immune-mediated adverse reactions (ARs) occurred in 21 percent of patients treated with Libtayo ® and led to permanent discontinuation in 4.6 The most common immune-mediated ARs were hypothyroidism (6.8 percent), hyperthyroidism (3 percent), immune-mediated pneumonitis (2.6 percent), immune-mediated hepatitis (2.4

article thumbnail

Non-vaccine nasal spray could protect against COVID-19

pharmaphorum

That could be important if it takes longer than expected to bring vaccines and antibodies to market, said a spokesman for the companies, pointing to the news this week that AstraZeneca has halted phase 3 trials of its COVID-19 vaccine candidate AZD1222 after a serious adverse reaction in one patient.

Vaccines 133